Israeli startups in the second cohort of i2i’s IP2 LaunchPad, 2021. Photo by Nati Levi courtesy of i2i
Taiwanese incubator’s success in connecting Israeli startups to its ecosystem leads to similar programs targeting North America and Europe.
Israeli startups looking to penetrate the Taiwanese market have a friend in the i2i (Innovation to Industry) company’s IP2 LaunchPad, opened in Israel in June 2020. IP2 ran two cohorts so far in Israel. Based on that success, i2i is now expanding the IP2 LaunchPad, first in Canada and Australia and next in the UK, The Netherlands and Sweden. Among Israeli IP2 LaunchPad alumni are:
ReSymmetry, which has signed a joint venture agreement with Karma Medical Products in Taiwan to produce smart robotic wheelchairs.
QualityLine, an AI-based manufacturing quality control company, which is partnering with Might Electronic Group.
Israeli med-tech startup OutSense Diagnostics, which signed a clinical trial agreement with Show Chwan, a major Taiwanese health system.
Registration for the third cohort in Israel has begun. “Ten companies will be selected in the fields of digital health, cybersecurity and renewable energy,” said Rani Shifron, who heads the incubator program in Israel.
Participating companies are given the opportunity to work out of the $2.5 billion “Startup Terrace” innovation center in Taipei. Startup Terrace is supported by the Taiwanese Ministry of the Economy and houses 106 entrepreneurs from over a dozen countries.
There’s also a program for veterans of the incubator and for established Israeli companies looking to enter new markets; and IP2 Sustainability, which operates in cooperation with the Israeli NGO Start-Up Nation Central.
“Israel’s innovativeness is known all over the world, and I am happy at the expansion of our existing cooperative efforts and at the creation of cooperative efforts between Israel and Taiwan in new areas through the IP2 LaunchPad program,” said Stanley Tzu-An Tseng, director of Taipei’s Economic and Cultural Office in Tel Aviv.
For more information, click here.
Comments